Hair Relaxer Lawsuit Regular exposure to chemicals in hair relaxer may cause uterine cancer, ovarian cancer and other injuries. Women diagnosed with cancer may be eligible for settlement benefits.
Depo-Provera Lawsuit Depo-Provera lawsuits are being investigated for women who developed meningioma brain tumors after receiving Depo-Provera birth control shots, claiming that Pfizer failed to adequately disclose side effects.
Nitrous Oxide Lawsuit Individuals who suffered harm, or families who lost a loved one after using nitrous oxide products may be eligible for financial compensation through a nitrous oxide lawsuit.
Sports Betting Addiction Lawsuit Sports betting addiction lawsuits are being investigated for college students and young adults who developed gambling problems after using apps like FanDuel and DraftKings, alleging that the platforms failed to warn about the addictive nature of their features and marketing practices.
Dupixent Lawsuit Dupixent lawsuits are being investigated for patients who developed rare blood cancers such as cutaneous T-cell lymphoma (CTCL) after receiving injections, alleging that Sanofi and Regeneron failed to warn about the potential risks of immune suppression and delayed cancer diagnosis.
Tabletop Fire Pit Lawsuit Individuals who suffered severe burns, or families who lost a loved one in a tabletop fire pit explosion, may be eligible for financial compensation through a fire pit injury lawsuit.
Roblox Lawsuit Families are filing Roblox lawsuits after children were targeted by predators for grooming, sextortion, sexual abuse, or exploitation on the platform. Learn who qualifies, what cases allege, and how to file a confidential claim.
Ozempic Lawsuit Lawyers are pursuing Ozempic lawsuits, Wegovy lawsuits and Mounjaro lawsuits over gastroparesis or stomach paralysis, which can leave users with long-term gastrointestinal side effects
Suboxone Tooth Decay Lawsuit Lawsuits are being pursued by users of Suboxone who experienced tooth loss, broken teeth or required dental extractions. Settlement benefits may be available.
Change Healthcare Lawsuit Lawyers are reviewing Change Healthcare class action lawsuits for individuals who had their personal information stolen due to the data breach.
Investor Arbitration Process Changes May Threaten Neutrality, Fairness: Lawyers November 5, 2015 Irvin Jackson Add Your Comments A group representing stock broker fraud attorneys are expressing concerns about a newly proposed rule by the independent financial system regulatory agency that presides over investor arbitration claims, indicating that the changes may reduce fairness and skew results more in favor of brokerage firms and the financial industry. The Financial Industry Regulatory Authority (FINRA) published a Federal Register notice (PDF) on October 13, indicating that it plans to merge FINRA Dispute Resolution, Inc. with its main regulatory arm. The public comment period for the proposed rule change was only open until Tuesday, and a final decision is expected to be made by the U.S. Securities and Exchange Commission (SEC) by November 27. Do You Know about… SPORTS BETTING ADDICTION LAWSUITS FOR YOUNG ADULTS Gambling addiction and severe financial losses have been linked to popular sports betting platforms like DraftKings, FanDuel, and Caesars. Lawsuits are being filed by young adults and students who were targeted by deceptive promotions, addictive app features, and aggressive marketing tactics. See if you qualify for a sports betting addiction lawsuit. Learn More SEE IF YOU QUALIFY FOR COMPENSATION Do You Know About… SPORTS BETTING ADDICTION LAWSUITS FOR YOUNG ADULTS Gambling addiction and severe financial losses have been linked to popular sports betting platforms like DraftKings, FanDuel, and Caesars. Lawsuits are being filed by young adults and students who were targeted by deceptive promotions, addictive app features, and aggressive marketing tactics. See if you qualify for a sports betting addiction lawsuit. Learn More SEE IF YOU QUALIFY FOR COMPENSATION FINRA is a non-governmental regulatory agency that oversees the financial industry and resolves disputes between investors and stock brokers or brokerage firms, including arbitration claims for fraud, breach of contract, breach of fiduciary duty, negligence, misrepresentation, unauthorized trading and other claims that investments were improperly handled. The agency originally broke off the Dispute Resolution division as a means of ensuring that the agency’s more than 6,000 arbitrators would treat disputes between customers and brokers fairly and independently. Critics say that this new move undoes those efforts, and may result in firms using decisions by FINRA Regulation, Inc. against customers, which was supposedly never intended. On November 2, the Public Investors Arbitration Bar Association (PIABA) objected to the move in a press release, saying it threatens the fairness and neutrality of the investor dispute resolution process. The group also objected to the swift speed toward a decision and the short comment period, which only provides a little more than two weeks. “What is the rush here?” asked PIABA President Hugh Berkson in the statement. “Why leave the impression that this is being slammed through before the public can get wind of this change? Why would the SEC even consider taking further chances with investor confidence in the already troubled FINRA arbitration system?” Berkson called for an extension of the public comment period to give concerned parties time to actually study the proposed change and comment. FINRA was created in July 2007, as a successor to the National Association of Securities Dealers (NASD), handling all disputes between investors and stockbrokers or other financial firms. Investors are required to pursue claims against stock brokers or brokerage firms through the FINRA arbitration process, as opposed to pursuing the cases in court. According to the Federal Register notice: “FINRA believes there is no longer a need to maintain separate subsidiaries to execute its regulatory and dispute resolution functions. The proposed merger would align the corporate legal structure with current public perception and organizational practice. It would also reduce unnecessary administrative burdens required to maintain separate legal entities.” The SEC approved the separation of the dispute resolution arm of FINRA in a 2000 decision, when FINRA was known as NASD. The SEC said that the change was designed to prevent fraudulent and manipulative actions, and make the process more independent. PIABA officials are asking what changed. “Basically, we think FINRA and the SEC got it 100 percent right 15 years ago when they created the independent subsidiary now known as FINRA Dispute Resolution,” Berkson said. “However, real concerns exist today about the fairness and neutrality of FINRA-run arbitration. As such, the proposed rule change would be a huge step backward to, in essence, put the chicken coop back into the fox den.” Written by: Irvin Jackson Senior Legal Journalist & Contributing Editor Irvin Jackson is a senior investigative reporter at AboutLawsuits.com with more than 30 years of experience covering mass tort litigation, environmental policy, and consumer safety. He previously served as Associate Editor at Inside the EPA and contributes original reporting on product liability lawsuits, regulatory failures, and nationwide litigation trends. Tags: FINRA, FINRA Arbitration, Investment Arbitration More Lawsuit Stories Mother’s Lawsuit Indicates 5-Year-Old Girl Sexually Exploited on Roblox October 10, 2025 Lawyers in Talcum Powder Bellwether Lawsuit To Meet for Final Pretrial Conference Nov. 5 October 10, 2025 Ambiano Electric Pressure Cooker Recall Due to Burn Injury Risks October 10, 2025 0 Comments PhoneThis field is for validation purposes and should be left unchanged.Share Your CommentsFirst Name*Last NameEmail* Shared Comments*This field is hidden when viewing the formI authorize the above comments be posted on this page Yes No Post Comment I authorize the above comments be posted on this page Weekly Digest Opt-In Yes, send me a weekly email with the latest lawsuits, recalls and warnings. Want your comments reviewed by a lawyer?To have an attorney review your comments and contact you about a potential case, provide your contact information below. This will not be published.Contact Phone #Alt Phone #Private CommentsNOTE: Providing information for review by an attorney does not form an attorney-client relationship.CAPTCHAGA SourceGA CampaignGA MediumGA ContentGA Term Δ MORE TOP STORIES Mother’s Lawsuit Indicates 5-Year-Old Girl Sexually Exploited on Roblox (Posted: 3 days ago) A new lawsuit against Roblox alleges that the platform’s inadequate safety measures enabled multiple sexual predators to exploit a five-year-old girl. MORE ABOUT: ROBLOX LAWSUITRoblox Sextortion Lawsuit Alleges Teen Committed Suicide After Being Groomed, Blackmailed (10/02/2025)MDL Sought for Roblox Lawsuits Over Child Sexual Exploitation and Assault Epidemic (09/23/2025)Safety Problems With Roblox and Discord Endangered Young Girl: Lawsuit (09/16/2025) Breast Mesh Lawsuits May Follow Recent Studies Highlighting Internal Bra Complications (Posted: 4 days ago) Breast mesh implants promoted as internal bras are now under scrutiny, following studies and FDA warnings linking the devices to infections, implant loss, and surgical failure. Lawsuits are being investigated for women who suffered complications after reconstruction or augmentation procedures involving products like GalaFLEX, Phasix, Strattice, and AlloDerm. MORE ABOUT: BREAST MESH LAWSUITFDA Warns BD Surgical Mesh Products Not Proven Safe for Breast Reconstruction Surgery (11/10/2023) Dupixent Cancer Risks Outlined in User Stories, as Evidence Mounts of T-Cell Lymphoma Link (Posted: 5 days ago) Dupixent users are coming forward with accounts of devastating cancer diagnoses, saying the popular eczema drug masked early warning signs of cutaneous T-cell lymphoma. As the FDA investigates and the first lawsuit is filed, researchers warn Dupixent may unmask or accelerate hidden cancers, raising urgent questions about its long-term safety. MORE ABOUT: DUPIXENT LAWSUITDupixent Wrongful Death Lawsuit Filed Over T-Cell Lymphoma Diagnosis (10/02/2025)Dupixent Cutaneous T-Cell Lymphoma Warning Label Update Being Evaluated by FDA (09/15/2025)Dupixent T-Cell Lymphoma Lawsuits May Follow Recent Studies Linking Drug to Cancer Risks (09/04/2025)
Lawyers in Talcum Powder Bellwether Lawsuit To Meet for Final Pretrial Conference Nov. 5 October 10, 2025
Mother’s Lawsuit Indicates 5-Year-Old Girl Sexually Exploited on Roblox (Posted: 3 days ago) A new lawsuit against Roblox alleges that the platform’s inadequate safety measures enabled multiple sexual predators to exploit a five-year-old girl. MORE ABOUT: ROBLOX LAWSUITRoblox Sextortion Lawsuit Alleges Teen Committed Suicide After Being Groomed, Blackmailed (10/02/2025)MDL Sought for Roblox Lawsuits Over Child Sexual Exploitation and Assault Epidemic (09/23/2025)Safety Problems With Roblox and Discord Endangered Young Girl: Lawsuit (09/16/2025)
Breast Mesh Lawsuits May Follow Recent Studies Highlighting Internal Bra Complications (Posted: 4 days ago) Breast mesh implants promoted as internal bras are now under scrutiny, following studies and FDA warnings linking the devices to infections, implant loss, and surgical failure. Lawsuits are being investigated for women who suffered complications after reconstruction or augmentation procedures involving products like GalaFLEX, Phasix, Strattice, and AlloDerm. MORE ABOUT: BREAST MESH LAWSUITFDA Warns BD Surgical Mesh Products Not Proven Safe for Breast Reconstruction Surgery (11/10/2023)
Dupixent Cancer Risks Outlined in User Stories, as Evidence Mounts of T-Cell Lymphoma Link (Posted: 5 days ago) Dupixent users are coming forward with accounts of devastating cancer diagnoses, saying the popular eczema drug masked early warning signs of cutaneous T-cell lymphoma. As the FDA investigates and the first lawsuit is filed, researchers warn Dupixent may unmask or accelerate hidden cancers, raising urgent questions about its long-term safety. MORE ABOUT: DUPIXENT LAWSUITDupixent Wrongful Death Lawsuit Filed Over T-Cell Lymphoma Diagnosis (10/02/2025)Dupixent Cutaneous T-Cell Lymphoma Warning Label Update Being Evaluated by FDA (09/15/2025)Dupixent T-Cell Lymphoma Lawsuits May Follow Recent Studies Linking Drug to Cancer Risks (09/04/2025)